#medicaltechnology

[ptseti]

📰 China shocks the world: Diabetes “cured”

🧬 Stem cell research shows insulin production can be restored 💉 Lab-grown cells successfully produce insulin 🩺 Potential breakthrough for Type 1 diabetes 🌍 Offers hope to millions worldwide

China's Breakthrough in Diabetes Treatment: Insulin Restoration Through Stem Cells Discover the revolutionary stem cell research restoring insulin production for diabetes. A potential game-changer for millions.

[entailglobal]

Spasmolytic therapy with Phloroglucinol + Trimethylphloroglucinol suppositories

Today, Centurion Healthcare is a respected Phloroglucinol 150 mg + Trimethylphloroglucinol 150 mg suppository exporter in India, helping mee

Phloroglucinol 150 mg + Trimethylphloroglucinol 150 mg suppository manufacturer in India | centurionhealthcare

Centurion Healthcare Private Limited is a trusted Phloroglucinol 150 mg + Trimethylphloroglucinol 150 mg suppository manufacturer in India, committed to delivering high-quality pharmaceutical solutions. We are a leading Phloroglucinol 150 mg + Trimethylphloroglucinol 150 mg suppository supplier in India, catering to hospitals, clinics, and distributors with products that meet international quality standards. As a reliable Phloroglucinol 150 mg + Trimethylphloroglucinol 150 mg suppository exporter in India, we ensure timely delivery and safe packaging for domestic and global clients. Partner with us for premium-quality suppositories crafted with precision and care.

Contact Centurion Healthcare today to place your order and experience excellence in pharmaceutical supply!

[databook9]

MEA TAVR Market Poised for Strong Growth as Advanced Cardiac Care Expands Across the Region

The MEA transcatheter aortic valve replacement (TAVR) market is entering a period of significant growth, fueled by improving healthcare infrastructure, favorable government healthcare policies, and a steadily increasing elderly population. As cardiovascular diseases continue to rise across the region, healthcare providers are increasingly adopting minimally invasive treatment options such as TAVR to improve patient outcomes while reducing recovery times.

The MEA TAVR market was valued at approximately USD 300.00 million in 2025 and is expected to reach nearly USD 974.20 million by 2035, registering an impressive CAGR of 12.50% from 2026 to 2035. The growing burden of aortic stenosis, combined with increased access to advanced cardiac procedures, is creating substantial opportunities for market expansion.

Key Growth Drivers

The rising prevalence of heart valve disorders among aging populations remains one of the primary factors driving demand for TAVR procedures. Unlike traditional open-heart surgery, TAVR offers a less invasive approach that can significantly reduce hospital stays and recovery periods, making it an attractive option for both patients and healthcare providers.

Governments and healthcare organizations across the MEA region are also investing heavily in modern healthcare facilities, advanced diagnostic technologies, and specialized cardiovascular treatment centers. These investments are helping improve access to innovative structural heart therapies and accelerating the adoption of TAVR procedures.

Additionally, ongoing technological advancements in valve design, delivery systems, and procedural techniques continue to improve clinical outcomes and expand patient eligibility.

Future Outlook

The outlook for the MEA TAVR market remains highly promising as healthcare systems continue to modernize and demand for advanced cardiovascular treatments increases. Rising awareness of minimally invasive procedures, supportive healthcare policies, expanding healthcare investments, and ongoing technological innovations are expected to fuel sustained market growth throughout the forecast period.

As access to specialized cardiac care improves across the region, TAVR is expected to become an increasingly important treatment option for patients suffering from severe aortic stenosis, supporting better clinical outcomes and transforming the future of structural heart disease management in the Middle East and Africa.

𝐘𝐨𝐮 𝐜𝐚𝐧 𝐩𝐥𝐚𝐜𝐞 𝐚𝐧 𝐨𝐫𝐝𝐞𝐫 𝐨𝐫 𝐚𝐬𝐤 𝐚𝐧𝐲 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬, 𝐩𝐥𝐞𝐚𝐬𝐞 𝐟𝐞𝐞𝐥 𝐟𝐫𝐞𝐞 𝐭𝐨 𝐜𝐨𝐧𝐭𝐚𝐜𝐭 𝐮𝐬 𝐚𝐭 𝐬𝐚𝐥𝐞𝐬@𝐩𝐫𝐞𝐜𝐞𝐝𝐞𝐧𝐜𝐞𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡.𝐜𝐨𝐦

[innorkommedical]

INNORKOM INC-AM-1 Anesthesia Machine! 🏥💉

Looking for the ultimate precision and safety for your patients during surgeries? Meet the INNORKOM INC-AM-1 – a state-of-the-art anesthesia machine that combines cutting-edge technology, reliability, and ease of use。

✨ Features ✨ ✅ 10.4" TFT LCD Touch Screen for real-time monitoring ✅ Advanced Alarming & Sensors that keep everything in check ✅ Accurate Gas Flow Control – because your patients deserve comfort ✅ Durable, Compact Design – space-saving & sleek ✅ Customizable Options to suit your clinic's needs

Perfect for ICU, operation rooms, and anesthesiology departments. Whether you're working with pediatric or geriatric patients, this machine’s got you covered!

Why INNORKOM? 🔧 Precision & Reliability – Delivering consistent anesthesia during the most critical procedures. 🌍 Ships Worldwide – Get it to your clinic in just 5-7 days (when in stock)!

🩺 Applications:

Pediatric to Geriatric Care – Supports patients of all ages.

Versatile Use: ICUs, outpatient clinics, and emergency rooms.

点击链接了解更多信息，看看这台机器如何升级您诊所的麻醉能力。让我们谈谈精准度、安全性和创新。🙌

[ashtocker]

A New Breakthrough in Therapeutics

Sponsored Post: There have been reports that green leaf has going mainstream. However, it has been said that there’s quietly an even bigger trend in the space that the world needs to wake up to. The CBD industry is said to have a conservative estimate of about $16 billion in the United States by 2025. The widespread adoption of big pharma and therapeutic industries is said to believe to be the largest green leaf acquisition in history. Why not look for the best part in this article? It could mean profits of biblical proportion! 

Accordingly, green leaf is said to have numerous potential health benefits, including the potential aiding of chronic pain, alcoholism and drug addiction, depression, post-traumatic stress disorder, social anxiety, cancer, multiple sclerosis, and epilepsy. These other growth-oriented aerosol manufacturing sectors are said to have taken CBD consumption to a new level with what’s essentially a CBD inhaler. It was said that it’s still well on the way to potentially turning the lucrative green leaf industry upside down.

More about it, these other sectors were said to have been focusing on providing their customers with the most therapeutic and effective solutions. The purpose of this establishment was said to find new ways to leverage aerosol devices in our daily lives and effective delivery systems for supplement needs. These other sectors were said to believe in the highest quality ingredients and manufacturing practices to ensure that customers get the purest possible product produced to CPMG compliance. Check the disclaimer on the profile and landing page.

[luckyme-14]

“...Will never forget the order of draw ever again.”

[blaytttt]

100121

So these are 9 lectures to study and 14 laboratory topics to review for the exams next week. And I only have 2 weekends to catch up on all of it. Each lecture is around 5-8 pages (Which seems small but I swear to god the information is a lot in just one page). Am I fine? no

It's finally October! Which means I survived a whole month of 3rd year MT in Velez 😭. And I have to tell you, it's been really really hard. Everyday runs like a whole week because of how hectic and busy the schedule is. Our exams are literally at 7am so I have to wake up around 4am. And then the day drags on to laboratory oral recitations, lab exercises and lectures to catch up for another exam the next day.

The good thing tho, I think I may have adjusted already to this new system? My anxiety isn't that grave anymore compared to when I first started the semester, which makes me really really really glad.

[medtechmemes]

Eosinophil (seen under 100x oil immersion): a type of specialized immune cell that promotes inflammation and helps to fight infection. Eosinophils normally make up about 1-3% of leukocytes, are 12-17 microns in diameter, and have a bilobed nuclei. They feature trademark reddish-orange granules by which they can be easily identified. These granules may be marvelous to look at once prepared but before being stained with Romanowsky they do not have any color. They contain digestive enzymes that are not only toxic to parasitic intruders but to host tissues as well.

Eosinophilia, or an increase in eosinophils, may be caused by parasitic infection, hay fever, asthma, eczema, and many more. The immune system is pretty amazing due to the fact that it can send out different types of white blood cells based on what the body needs.

If any techs follow my page you may notice some other funky cells in the field with this lovely looking eos. In the student lab, we receive slides from local hospital donations and sometimes are unable to get a full history on the source patient. However, we do know that this patient is suffering from a leukemic process. (And some of our microscopes are quite worn out!)